No Data
No Data
LEGEND STRAT: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024
Express News | Legend Strategy International Holdings Group Company H1 Net Income Attributable HKD 3.2 Million
LEGEND STRAT: POSITIVE PROFIT ALERT
LEGEND STRAT: SUPPLEMENTAL FINANCIAL INFORMATION IN RELATION TO 2023 ANNUAL REPORT
Luye Pharma Group Ltd. (01355.HK) plans to hold a board meeting on August 30th to approve its interim performance.
On August 30, 2024, Friday, Lirui International (01355.HK) announced that the board of directors will hold a meeting to consider and approve the release of unaudited interim performance announcements for the company and its subsidiaries for the six months ended on June 30, 2024, as well as to consider and approve (if appropriate) the proposal for interim dividends (if any).
LEGEND STRAT: NOTICE OF BOARD MEETING
No Data